Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep;91(9):1004-1006.
doi: 10.1136/jnnp-2020-323678. Epub 2020 Jul 10.

COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network

Collaborators, Affiliations
Case Reports

COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network

Louis Delamarre et al. J Neurol Neurosurg Psychiatry. 2020 Sep.
No abstract available

Keywords: autoimmune encephalitis; intensive care; neuropathology, virology; steroids.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(I–III) MRI of a 51-year-old man with acute encephalopathy. (I) MRI 1 is not shown. MRI 2 (day 22) 1 day after neuroICU admission. (A–D) Axial FLAIR images demonstrate diffuse hyperintense lesions in the cerebellum (star), brainstem (arrows on B), supratentorial grey and white matters (arrows on D), and bilateral and symmetrical lesions in the thalami (arrows on C). (E) Gradient echo T2-weighted image does not reveal any haemorrhage within thalamic lesions, and (F) post-gadolinium T1-weighted image does not show enhancement. (G) Diffusion-weighted image and (H) apparent diffusion coefficient map show mild hyperintensity in the thalami with heterogeneous and variable diffusion (arrows). (II) MRI 3 (day 25) 3 days after treatment initiation: (A) axial FLAIR demonstrates no extension of hyperintensity in both thalami (arrows) and (B) susceptibility-weighted image does not detect any haemorrhage. (C) Diffusion-weighted image and (D) apparent diffusion coefficient map now depict areas of restricted diffusion and cytotoxic oedema (arrows), a feature highly suggesting acute necrotising encephalopathy. (III) MRI 4 (day 35) 13 days after treatment initiation: (A–C) axial FLAIR images demonstrate significant reduction of hyperintensities with only residual lesions in bilateral thalami (arrows). (D) Gradient echo T2-weighted image shows no haemorrhage within the lesions. (IV, V) Indirect immunofluorescence (IF) patterns of patient’s IgG on rat hippocampal slices (×10 magnification, scale bar 100 µm). IF shows an unusual binding of IgG on specific areas in the fibre tracts, sparing the hippocampus and the cortex, (IV) around the ventricle, near the dentate gyrus and (V) close to the hippocampus Ammon’s horn. Hi, hile of the dentate gyrus; GC, granule cells of the dentate gyrus; ML, molecular layer; Py, pyramidal cells in the hippocampus Ammon’s horn.

References

    1. Poyiadji N, Shahin G, Noujaim D, et al. . COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;2:1–9. - PMC - PubMed
    1. Wu X, Wu W, Pan W, et al. . Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm 2015;2015:1–10. 10.1155/2015/792578 - DOI - PMC - PubMed
    1. Wong AM, Simon EM, Zimmerman RA, et al. . Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006;27:1919–23. - PMC - PubMed
    1. Bookstaver PB, Mohorn PL, Shah A, et al. . Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis 2017;9:117957351770334. 10.1177/1179573517703342 - DOI - PMC - PubMed
    1. Mehta P, McAuley DF, Brown M, et al. . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4. 10.1016/S0140-6736(20)30628-0 - DOI - PMC - PubMed

MeSH terms